Clinical trials
Phase 2/3 COVID-19 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| Chromis LLC | 1 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 1 |
| Microgen | 1 |
| NPO Petrovax | 1 |
| National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia | 1 |
| R-Pharm International, LLC | 1 |
| RedHill Biopharma Limited | 1 |
| St. Petersburg Research Institute of Vaccines and Sera | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 13 |
| Coronavirus Infections | 3 |
| Lung Diseases | 1 |
| Respiration Disorders | 1 |
| Respiratory Tract Infections | 1 |
| Vaccine-Preventable Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.